Atea Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Atea Pharmaceuticals by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $25k | 7.5k | 3.35 |
2024-06-30 | $25k | 7.5k | 3.31 |
2024-03-31 | $30k | 7.5k | 4.04 |
2023-12-31 | $23k | 7.5k | 3.05 |
2023-09-30 | $15k | 5.1k | 3.00 |
2023-06-30 | $19k | 5.1k | 3.74 |
2023-03-31 | $17k | 5.1k | 3.35 |
2022-12-31 | $24k | 5.1k | 4.75 |
2022-09-30 | $28k | 5.1k | 5.53 |
2022-06-30 | $35k | 5.1k | 6.91 |
2022-03-31 | $37k | 5.1k | 7.31 |
2021-12-31 | $45k | 5.1k | 8.89 |
2021-09-30 | $178k | 5.1k | 35.15 |
2021-06-30 | $109k | 5.1k | 21.52 |
2021-03-31 | $75k | 1.2k | 61.73 |
2020-12-31 | $51k | 1.2k | 41.98 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors